Skip to main content
Clinical Trials/NCT02160236
NCT02160236
Unknown
Phase 4

Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam in Lumbar Disc Surgery

TC Erciyes University1 site in 1 country90 target enrollmentNovember 2014

Overview

Phase
Phase 4
Intervention
dexketoprofen trometamol
Conditions
Postoperative Pain
Sponsor
TC Erciyes University
Enrollment
90
Locations
1
Primary Endpoint
analgesic consumption
Last Updated
11 years ago

Overview

Brief Summary

In this study the investigators aimed to compare of postoperative analgesic effects of intravenous dexketoprofen trometamol and tenoxicam in lumbar disc surgery.

Detailed Description

Lumbar disc surgery is associated with moderate to severe back and radicular pain postoperatively which has unfavorable effects on patients recovery and procedures outcome. Dexketoprofen has been reported to be one of the NSAİDs that can provide good results when compared with narcotics in many painful conditions and especially in the treatment of the moderate to severe postoperative pain that may develop after lumbal disc surgery. Tenoxicam is a thienothiazine derivative of the oxicam class of NSAİDs. There are some studies in which NSAİDs have been used to together with opioids for postoperative analgesia showing that they decrease opioid consumption and side effects

Registry
clinicaltrials.gov
Start Date
November 2014
End Date
February 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nazife Küçük

resident

TC Erciyes University

Eligibility Criteria

Inclusion Criteria

  • between 18-65 age
  • elective lumbar disc surgery

Exclusion Criteria

  • history of gastrointestinal bleeding
  • peptic ulcer disease
  • bleeding disorders
  • history of allergic reactions to NSAİDs
  • chronic pain syndrome

Arms & Interventions

dexketoprofen trometamol

before end of the surgery via intravenous administration 50 mg dexketoprofen trometamol in 0.9 % NaCl 100 cc

Intervention: dexketoprofen trometamol

tenoxicam

before the end of the surgery via administration intravenous 20 mg tenoxicam in 0.9% NaCl in 100 cc

Intervention: tenoxicam

serum physiologic

before end of the surgery via administration intravenous 0.9 % NaCl 100 cc

Intervention: serum physiologic

Outcomes

Primary Outcomes

analgesic consumption

Time Frame: postoperative 1 day

morphine consumption (patient control analgesia procedure) was recorded

Secondary Outcomes

  • visual analog scale(postoperative 1 day)

Study Sites (1)

Loading locations...

Similar Trials